False Positive results may be obtained with the identified lots of list 7B34-16 when using a negative patient sample or a negative control.
Source facts
Action
Abbott notified their affiliates in all four countries via e-mail on 3/16/05. Each Abbott international country organization is responsible for translating the customer letter, contacting customers and determining the method of effectiveness checks based on their country requirements. The recall letters inform the accounts of the false positve results, and were requested to destroy any remaining inventory of the affected lots.
Initiated
2005-03-16
Root cause
Other
Terminated
2006-05-25
Distribution
Canada, Germany, Hong Kong and Australia
Recall number
Z-1392-05
Recall status
Terminated
CDRH record ID
37946
FDA classified
2005-08-24
Recall event number
31466
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.